Literature DB >> 21942547

Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation.

Yulia Kaluzhny1, Helena Kandárová, Patrick Hayden, Joseph Kubilus, Laurence d'Argembeau-Thornton, Mitchell Klausner.   

Abstract

The recently implemented 7th Amendment to the EU Cosmetics Directive and the EU REACH legislation have heightened the need for in vitro ocular test methods. To address this need, the EpiOcular(TM) eye irritation test (EpiOcular-EIT), which utilises the normal (non-transformed) human cell-based EpiOcular tissue model, has been developed. The EpiOcular-EIT prediction model is based on an initial training set of 39 liquid and 21 solid test substances and uses a single exposure period and a single cut-off in tissue viability, as determined by the MTT assay. A chemical is classified as an irritant (GHS Category 1 or 2), if the tissue viability is ≤ 60%, and as a non-irritant (GHS unclassified), if the viability is > 60%. EpiOcular-EIT results for the training set, along with results for an additional 52 substances, which included a range of alcohols, hydrocarbons, amines, esters, and ketones, discriminated between ocular irritants and non-irritants with 98.1% sensitivity, 72.9% specificity, and 84.8% accuracy. To ensure the long-term commercial viability of the assay, EpiOcular tissues produced by using three alternative cell culture inserts were evaluated in the EpiOcular-EIT with 94 chemicals. The assay results obtained with the initial insert and the three alternative inserts were very similar, as judged by correlation coefficients (r²) that ranged from 0.82 to 0.96. The EpiOcular-EIT was pre-validated in 2007/2008, and is currently involved in a formal, multi-laboratory validation study sponsored by the European Cosmetics Association (COLIPA) under the auspices of the European Centre for the Validation of Alternative Methods (ECVAM). The EpiOcular-EIT, together with EpiOcular's long history of reproducibility and proven utility for ultra-mildness testing, make EpiOcular a useful model for addressing current legislation related to animal use in the testing of potential ocular irritants. 2011 FRAME.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21942547     DOI: 10.1177/026119291103900409

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  20 in total

1.  Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.

Authors:  Raja S Settivari; Nicholas Ball; Lynea Murphy; Reza Rasoulpour; Darrell R Boverhof; Edward W Carney
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

Review 2.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

3.  Establishment of a new immortalized human corneal epithelial cell line (iHCE-NY1) for use in evaluating eye irritancy by in vitro test methods.

Authors:  Naoki Yamamoto; Yoshinao Kato; Atsushi Sato; Noriko Hiramatsu; Hiromi Yamashita; Mahito Ohkuma; Ei-Ichi Miyachi; Masayuki Horiguchi; Koji Hirano; Hajime Kojima
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-29       Impact factor: 2.416

Review 4.  Role of In Vitro Models for Development of Ophthalmic Delivery Systems.

Authors:  Shallu Kutlehria; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

Review 5.  Same-chemical comparison of nonanimal eye irritation test methods: Bovine corneal opacity and permeability, EpiOcular™, isolated chicken eye, ocular Irritection®, OptiSafe™, and short time exposure.

Authors:  Stewart Lebrun; Linda Nguyen; Sara Chavez; Roxanne Chan; Debby Le; Minh Nguyen; James V Jester
Journal:  Toxicol In Vitro       Date:  2020-12-19       Impact factor: 3.500

Review 6.  Nanostructure-based platforms-current prospective in ophthalmic drug delivery.

Authors:  Rakesh Kumar Sharma; Alaa Eldeen B Yassin
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

7.  Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay.

Authors:  Susanne N Kolle; Ursula G Sauer; Maria C Rey Moreno; Wera Teubner; Wendel Wohlleben; Robert Landsiedel
Journal:  Part Fibre Toxicol       Date:  2016-04-15       Impact factor: 9.400

8.  Evaluation of Eye Irritation Potential of Solid Substance with New 3D Reconstructed Human Cornea Model, MCTT HCE(TM).

Authors:  Won-Hee Jang; Kyoung-Mi Jung; Hye-Ri Yang; Miri Lee; Haeng-Sun Jung; Su-Hyon Lee; Miyoung Park; Kyung-Min Lim
Journal:  Biomol Ther (Seoul)       Date:  2015-07-01       Impact factor: 4.634

9.  Retrospective analysis of the Draize test for serious eye damage/eye irritation: importance of understanding the in vivo endpoints under UN GHS/EU CLP for the development and evaluation of in vitro test methods.

Authors:  Els Adriaens; João Barroso; Chantra Eskes; Sebastian Hoffmann; Pauline McNamee; Nathalie Alépée; Sandrine Bessou-Touya; Ann De Smedt; Bart De Wever; Uwe Pfannenbecker; Magalie Tailhardat; Valérie Zuang
Journal:  Arch Toxicol       Date:  2013-12-28       Impact factor: 5.153

10.  Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories.

Authors:  Michaela Zorn-Kruppa; Pia Houdek; Ewa Wladykowski; Maria Engelke; Melinda Bartok; Karsten R Mewes; Ingrid Moll; Johanna M Brandner
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.